Stockreport

Viatris Announces Launch of First Bioequivalent Generic Version of Copaxone® 20 mg/mL Once-Daily in Canada [Yahoo! Finance]

Viatris Inc.  (VTRS) 
PDF ETOBICOKE, ON April 15, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced the launch in Canada of Pr Glatiramer Acetate Inj [Read more]